DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma

Carcinogenesis
Magdalena Kostrzewska-PoczekajMaciej Giefing

Abstract

Low 5-year survival rate in laryngeal squamous cell carcinoma (LSCC) is to large extent attributable to high rate of recurrences and metastases. Despite the importance of the latter process, its complex genetic background remains not fully understood. Recently, we identified two metastasis-related candidate genes, DIAPH2 and DIAPH3 to be frequently targeted by hemizygous/homozygous deletions, respectively, in LSCC cell lines. They physiologically regulate such processes as cell movement and adhesion, hence we found it as a rationale, to study if tumor LSCC specimens harbor mutations of these genes and whether the mutations are associated with metastasizing tumors. As a proof of concept, we sequenced both genes in five LSCC cell lines derived from lymph node metastases assuming there the highest probability of finding alterations. Indeed, we identified one hemizygous deletion (c.3116_3240del125) in DIAPH2 targeting the FH2 domain. Moreover, we analyzed 95 LSCC tumors (53 N0 and 42 N+) using the Illumina platform and identified three heterozygous single nucleotide variants in DIAPH2 targeting conserved domains exclusively in N+ tumors. By combining these results with cBioPortal data we showed significant enrichment of DIAPH2 muta...Continue Reading

References

Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F LeviC La Vecchia
May 4, 2005·Molecular Cell·Takanori OtomoMichael K Rosen
Dec 13, 2006·Biophysical Journal·Tom Shemesh, Michael M Kozlov
Jan 23, 2009·Molecular and Cellular Biology·Jae Ryun RyuAnn Marie Pendergast
Aug 20, 2009·Molecular Biology Reports·Katarzyna KiwerskaKrzysztof Szyfter
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Jan 1, 2010·Cancer Biomarkers : Section a of Disease Markers·Magdalena Kostrzewska-PoczekajKrzysztof Szyfter
Jan 17, 2012·The Journal of Biological Chemistry·Naomi Courtemanche, Thomas D Pollard
May 18, 2012·EMBO Molecular Medicine·Martin H HagerMichael R Freeman
May 23, 2012·Cancer Discovery·Tsukasa ShibueRobert A Weinberg
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Jan 9, 2015·G3 : Genes - Genomes - Genetics·Léna VouillotNicolas Pollet
Dec 7, 2016·Nature Communications·J C ErasmusV M M Braga
Aug 3, 2017·Journal of Surgical Oncology·Shonan ShoJames S Tomlinson

❮ Previous
Next ❯

Citations

Oct 28, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Wenfei LiZhanqiu Wang
Jul 25, 2021·International Journal of Environmental Research and Public Health·Mirosław ŚnitWładysław Grzeszczak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.